Indivior Pharmaceuticals Inc
INDV
Clasificación en acciones
#3876
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Precio por acción
$34.01
Última sincronización: 2026-10-19
Capitalización bursátil
$4.24B
Cambio (1 día)
4.81%
Cambio (1 año)
40.02%
País
US
Comercio Indivior Pharmaceuticals Inc (INDV)
Categoría
Healthcare
Ganancias de Indivior Pharmaceuticals Inc (INDV)
Ganancias en Jun 2026 TTM: $393.00M
Secondo gli ultimi rapporti finanziari di Indivior Pharmaceuticals Inc, gli utili attuali della società sono $393.00M. Nel 2023, la società ha registrato un utile di $-149.00M, una disminución en comparación con agli utili del 2022, che erano di $-89.00M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Indivior Pharmaceuticals Inc desde 2016 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $393.00M | 2,707.14% |
| 2024 | $14.00M | -109.40% |
| 2023 | $-149.00M | 67.42% |
| 2022 | $-89.00M | -146.84% |
| 2021 | $190.00M | -209.83% |
| 2020 | $-173.00M | -196.11% |
| 2019 | $180.00M | -32.21% |
| 2018 | $265.53M | 84.52% |
| 2017 | $143.91M | 60.35% |
| 2016 | $89.75M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 349.00% |
IN
|
